A lower rate of preterm birth after clotrimazole therapy during pregnancy

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Topical or vaginal clotrimazole treatment during pregnancy was evaluated in the large population-based control data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-92. The database comprised 32,804 control non-malformed newborn infants, 7.7% of whom were born to mothers who had received clotrimazole treatment during pregnancy. An increase in mean gestational age among exposed vs. unexposed was found. It is postulated that the use of clotrimazole during pregnancy reduced significantly the proportion of preterm births because of the effective treatment of genital infections caused by candidiasis in pregnant women.

Original languageEnglish
Pages (from-to)58-64
Number of pages7
JournalPaediatric and Perinatal Epidemiology
Volume13
Issue number1
DOIs
Publication statusPublished - 1999

Fingerprint

Clotrimazole
Premature Birth
Pregnancy
Population Control
Candidiasis
Gestational Age
Pregnant Women
Therapeutics
Mothers
Newborn Infant
Databases
Infection

ASJC Scopus subject areas

  • Epidemiology
  • Pediatrics, Perinatology, and Child Health

Cite this

A lower rate of preterm birth after clotrimazole therapy during pregnancy. / Czeizel, E.; Rockenbauer, M.

In: Paediatric and Perinatal Epidemiology, Vol. 13, No. 1, 1999, p. 58-64.

Research output: Contribution to journalArticle

@article{c65271b8815e436a985accf97c30afb6,
title = "A lower rate of preterm birth after clotrimazole therapy during pregnancy",
abstract = "Topical or vaginal clotrimazole treatment during pregnancy was evaluated in the large population-based control data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-92. The database comprised 32,804 control non-malformed newborn infants, 7.7{\%} of whom were born to mothers who had received clotrimazole treatment during pregnancy. An increase in mean gestational age among exposed vs. unexposed was found. It is postulated that the use of clotrimazole during pregnancy reduced significantly the proportion of preterm births because of the effective treatment of genital infections caused by candidiasis in pregnant women.",
author = "E. Czeizel and M. Rockenbauer",
year = "1999",
doi = "10.1046/j.1365-3016.1999.00157.x",
language = "English",
volume = "13",
pages = "58--64",
journal = "Paediatric and Perinatal Epidemiology",
issn = "0269-5022",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - A lower rate of preterm birth after clotrimazole therapy during pregnancy

AU - Czeizel, E.

AU - Rockenbauer, M.

PY - 1999

Y1 - 1999

N2 - Topical or vaginal clotrimazole treatment during pregnancy was evaluated in the large population-based control data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-92. The database comprised 32,804 control non-malformed newborn infants, 7.7% of whom were born to mothers who had received clotrimazole treatment during pregnancy. An increase in mean gestational age among exposed vs. unexposed was found. It is postulated that the use of clotrimazole during pregnancy reduced significantly the proportion of preterm births because of the effective treatment of genital infections caused by candidiasis in pregnant women.

AB - Topical or vaginal clotrimazole treatment during pregnancy was evaluated in the large population-based control data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-92. The database comprised 32,804 control non-malformed newborn infants, 7.7% of whom were born to mothers who had received clotrimazole treatment during pregnancy. An increase in mean gestational age among exposed vs. unexposed was found. It is postulated that the use of clotrimazole during pregnancy reduced significantly the proportion of preterm births because of the effective treatment of genital infections caused by candidiasis in pregnant women.

UR - http://www.scopus.com/inward/record.url?scp=0032950225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032950225&partnerID=8YFLogxK

U2 - 10.1046/j.1365-3016.1999.00157.x

DO - 10.1046/j.1365-3016.1999.00157.x

M3 - Article

VL - 13

SP - 58

EP - 64

JO - Paediatric and Perinatal Epidemiology

JF - Paediatric and Perinatal Epidemiology

SN - 0269-5022

IS - 1

ER -